Fact.MR, Rockville MD: Award winning market research company Fact.MR’s ongoing closed blood sampling systems market study predicts an optimistic scenario through 2021, building upon previously accrued gains.
Rising incidences of chronic cancers and risks of wound infections are accelerating uptake
Fact.MR, Rockville MD: Award winning market research company Fact.MR’s ongoing closed blood sampling systems market study predicts an optimistic scenario through 2021, building upon previously accrued gains. Demand for closed blood sampling systems witnessed a massive spike through 2020, with the coronavirus pandemic necessitating voluminous blood sampling exercises.
Additionally, growth is further stimulated due to the unprecedented increase in surgeries. The International Society of Aesthetic Plastic Surgery (ISAPS), reports a 7.4% incline in surgeries, mostly cosmetic procedures. Moreover, as per a study published in the Lancet established that at least 5 billion people lack access to safe and affordable surgical anesthesia, mostly across low and middle income countries. Hence, blood loss due to surgery and infection risks are immense.
In addition, the American Cancer Society establishes that over 1.8 million people were expected to be diagnosed with cancer as of 2020, many of whom require daily blood doses during their chemotherapy treatment. Approximately 36,000 units of red blood cells are required daily across the US, while platelets and plasma requirements amount to 7,000 and 10,000 units respectively. Also, with almost 100,000 patients afflicted with sickle cell disease, requirement for safe and pure blood has become a necessity.
“Compounding incidences of trauma and surgical wounds combined with inadequate access to safe procedures is compelling healthcare providers to invest in closed blood sampling systems instead of traditional ones,” says the Fact.MR analyst.
Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4002
Key Takeaways from Fact.MR’s Blood Sampling Systems Market Study
- By product type, closed blood sampling systems are poised to account for the lion’s share
- Closed blood sampling systems for treatment applications are expected to gain momentum
- Blood collection centers shall emerge as the primary closed blood sampling systems end-users
- US to generate impressive growth prospects amid rising chemotherapy procedures which required high blood volumes
- Progressive blood donation policies for homosexual individuals to augment closed blood sampling systems sales in the UK
- Robust blood donation and sampling guidelines to bolster uptake across Germany and France
- India to experience high sales amid burgeoning initiatives by the government to rein in episodes of bacterial contamination
Closed Blood Sampling Systems Market- Prominent Drivers
- Rising incidences of trauma and surgical wounds has widened uptake of closed blood sampling systems to prevent contamination
- Success rates in reducing iatrogenic blood loss amongst pediatric patients to further future sales
- Growing demand for blood donations to fulfil various blood transfusion requirements is stimulating the need for closed blood sampling systems
Closed Blood Sampling Systems Market- Key Restraints
- Inadequate awareness regarding the potential benefits of closed systems is likely to impede growth
- Non-uniform implementation and enforcement policies is restraining large scale adoption
Discover more about the closed blood sampling system market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/4002/closed-blood-sampling-systems-market
Competitive Landscape
Key market players operating in the closed blood sampling system market include ICU Medical Inc., Smiths Medical, Edwards Lifesciences Corporation, Ashcon International, CardioMed Supplies Inc., Velano Vascular, Inc., Merit Medical Systems and Argon Medical among others.
ICU Medical Inc.’s SafeSet® offers closed, in-line blood conservation systems (BCS) eliminates the need to discard the clearing volume associated with sampling through indwelling arterial catheters, reducing blood loss as well as the potential for bacterial ingress into the closed system. Prevention of microbial contamination is further enhanced by incorporating needle free connectors into the sampling port stopcock.
Likewise, Smiths Medical offers the ViaValve® Winged Safety IV Catheters which provide blood control to help reduce the risk of blood exposure and contamination. Its Straight Hub (Orange), radiopaque, 14 g x 1 ¼” polyurethane catheter offers a flow rate of 360 mL/min. A unique valve inside the catheter hub impedes blood flow from the patient’s vein upon initial venipuncture.
More Insights on the Closed Blood Sampling System Market
In its ongoing study, Fact.MR offers unbiased analysis of the global closed blood sampling system market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (system and accessories), application (treatment and diagnostic) and end users (hospitals, nursing homes, ambulatory surgery centers, intensive care units, clinics, pathology labs and blood collection centers) across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).
Request For No-Obligation Table Of Content
https://www.factmr.com/connectus/sample?flag=T&rep_id=4002
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Market Intelligence Services: Marketngage.com
Source: Fact.MR